With over 15 years of experience, Josh Elliott focuses on patent law matters related to biochemistry and biotechnology, including advising and counseling clients on issues such as freedom-to-operate, infringement, validity, and design around strategies. His practice includes rendering opinions, conducting patent due diligence investigations, advising clients on patent portfolio strategies, strategically managing global patent portfolios, and preparing and prosecuting patent applications. Mr. Elliott also has experience advising clients on due diligence issues related to potential investments, venture funding, and initial public offerings.

Representative Experience

Mr. Elliott has particular experience in advising biotechnology companies on patent issues related to advancing products to market, including agricultural and biotherapeutic products.

He has worked on patent matters in diverse technologies, including:

  • Plant biotechnology
  • Industrial/enzyme biotechnology
  • Nucleic acid and protein technologies
  • Therapeutic antibodies
  • RNA interference
  • Metabolomics
  • Proteomics
  • Vaccines
  • Small molecule pharmaceuticals

Background and Credentials

Mr. Elliott earned his J.D., cum laude, from the University of Dayton School of Law, where he was the recipient of the Loren M. Berry Scholarship. During law school, he was a member of the University of Dayton Law Review. He graduated with a B.S. in chemistry on the biochemistry track, with Distinction, from the University of North Carolina at Chapel Hill, where he was elected to the Phi Beta Kappa honor society.

Prior to attending law school, Mr. Elliott was a field scientist with Research Triangle Institute.


  • University of Dayton School of Law (J.D., cum laude)
  • University of North Carolina at Chapel Hill (B.S., with distinction)
    • Chemistry (Biochemistry track)

Bar Admissions

  • North Carolina

Publications and Presentations

  • “2013 Intellectual Property Law Update,” Association of Corporate Counsel, RTP Chapter, Research Triangle Park, NC, December 18, 2013.
  • “Recent Court Decisions that Affect your Patent Rights,” The Laws of Science: Understanding Intellectual Property for the Life Sciences, Durham, NC, March 29, 2012.
  • “2011 Intellectual Property Law Update,” Association of Corporate Counsel, RTP Chapter, Research Triangle Park, NC, December 7, 2011.
  • “Confronting the Written Description Requirement Post-Centocor and Evaluating its Impact on Biotech Patent Practices,” ACI’s Conference on Biotech Patents, Boston, Mass., December 1, 2011.

Community and Professional Involvement

  • North Carolina Bar Association, Co-chair, Chemical and Biotechnology Patents Committee, 2007–2010